StockDuty ← Dashboard Aug 28, 2026 02:04 PM ET
CatalystFDA/Bio

FDA APPROVED GILEAD'S NEW ONCE-DAILY HIV PILL FOR PATIENTS ON COMPLEX REGIMENS - QZ

FDA approval expands Gilead's HIV market to complex-regimen patients.

FDA approval expands Gilead's HIV market to complex-regimen patients.
Sources